The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

MarketWatch

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

공식 발표 ↔ 진영별 보도

진보 성향 38%중도 성향 50%보수 성향 12%

3건4건1건

공식 발표 (2건) — 공공 라이선스 원문 직접 열람

진보 성향3

중도 성향4

보수 성향1

기타·국영 1

관련 뉴스 제보는 로그인 후 가능합니다.

'economy' 카테고리 뉴스

MarketWatch의 다른 기사

IBM lowered its guidance. Now it’s time to deliver, analysts say.

MarketWatch

Japan’s $1.8 trillion pension giant might bring money home. That could jolt U.S. stocks and the Fed.

MarketWatch

Lockheed Martin’s stock leaps as push to build more missiles faster pays off

MarketWatch

The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

이 뉴스, 어떠셨어요?

공식 발표 ↔ 진영별 보도

'economy' 카테고리 뉴스

I've been my mom's caregiver for 10 years. I'm running on empty.

Houthis strike Saudi tankers as Red Sea route unravels

IMF urges Ukraine to abolish windfall tax on bank profits after 2027

MarketWatch의 다른 기사

IBM lowered its guidance. Now it’s time to deliver, analysts say.

Japan’s $1.8 trillion pension giant might bring money home. That could jolt U.S. stocks and the Fed.

Lockheed Martin’s stock leaps as push to build more missiles faster pays off